China adds second GLP-1 diabetes drug to essential medicine list
6 Articles
6 Articles
China Adds Semaglutide, Cancer Drugs to Essential Medicines List After Eight-Year Gap
China Adds Semaglutide, Cancer Drugs to Essential Medicines List After Eight-Year Gap - First update in eight years brings innovative therapies into a state-backed catalog that shapes hospital purchasing and patient access
China adds second GLP-1 diabetes drug to essential medicine list
China will add a second GLP-1 drug, used to treat diabetes, to a list of essential drugs all public hospitals are required to prioritise having in their formulary, a government statement said on Thursday.
China will add a second GLP-1 medicine, a class popularly called weight loss pens, used to treat diabetes, to a list of essential remedies that all hospitals are obliged to prioritize in their formulas, reported a government statement on Thursday (9). Read more (07/09/2026
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
